Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Ann Vasc Surg ; 72: 196-204, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33388408

ABSTRACT

BACKGROUND: Coronavirus disease 2019 (COVID-19) infection can cause alterations in the coagulation mechanism conditioning thrombotic phenomena such as acute limb ischemia (ALI) as the only manifestation of the infection. The aim of the study was to describe clinical and surgical characteristics of a group of patients infected with severe acute respiratory syndrome coronavirus 2 who presented ALI in the context of the COVID-19 pandemic at Lima, Peru. METHODS: A multicenter, observational, and retrospective study was performed in six general hospitals, from March to July 2020. The variables considered were the pathological history and associated habits, laboratory tests, the severity of COVID-19 infection and ALI, the anatomic location of the lesion, treatment, evolution, and discharge conditions. RESULTS: Thirty patients with ALI infected with COVID-19 were evaluated. Their mean age was 60 ± 15 years, the condition being more frequent in men (76.6%). The main comorbidities were arterial hypertension (33.3%), obesity (33.3%), and diabetes mellitus 2 (26.6%). There were 23.3% asymptomatic patients, and their only manifestation was ALI. Rutherford IIA and IIB stage included 93.2% of patients. The most frequent location of the thrombosis was the lower limbs (73.3% vs. 26.6%). Thrombectomy was performed in 76.6% of the patients, and amputation (primary and secondary) was performed in 30% of the patients. The mortality rate was 23.3%, all of it because of acute respiratory distress syndrome. CONCLUSIONS: ALI is a vascular pathology associated with embolic and thrombotic processes. COVID-19 infection can cause severe alterations in coagulation mechanisms, leading some patients to present severe acute arterial complications such as thrombosis, as the only associated manifestation. We report a younger cohort than those described in other studies and with a high frequency of amputations despite adequate surgical treatment.


Subject(s)
COVID-19/complications , Ischemia/etiology , Ischemia/surgery , Lower Extremity/blood supply , Acute Disease , Amputation, Surgical , COVID-19/epidemiology , COVID-19/mortality , Female , Humans , Male , Middle Aged , Pandemics , Peru/epidemiology , Pneumonia, Viral/epidemiology , Pneumonia, Viral/mortality , Pneumonia, Viral/virology , Retrospective Studies , SARS-CoV-2 , Thrombectomy
2.
Fetal Diagn Ther ; 47(12): 873-881, 2020.
Article in English | MEDLINE | ID: mdl-32937625

ABSTRACT

OBJECTIVE: To report the experience with prenatal repair of open spina bifida (OSB) from 2 centers in Chile. METHODS: Women with a second-trimester fetus with OSB were offered intrauterine neurosurgical repair following the protocol from the Management of Myelomeningocele Study (MOMS) trial. Pediatric follow-up with infants reaching 12 and 30 months of life was also reviewed. RESULTS: Fifty-eight fetuses with OSB underwent intrauterine repair at an average (±SD) gestational age of 24.8 ± 0.9 weeks. There were 3 (5.1%) intrauterine deaths. The average gestational age at delivery of the remaining 55 cases was 33.3 ± 3.6 weeks, and the average birth weight was 2,172 ± 751 g. Delivery before 30 weeks occurred in 11 cases (20.0%). Two (3.6%) neonatal deaths (<28 days) occurred. At 12 months, a ventriculoperitoneal shunt or an endoscopic third ventriculostomy was required in 25% of the cases. At 30 months, 72.4% of the infants were able to walk. DISCUSSION: Prenatal neurosurgical repair of OSB is a complex and challenging intervention. Major complications include perinatal death and severe prematurity. No major maternal complications occurred in our series. A reduction in the need for cerebrospinal fluid diversion and an improved ability to walk seem to be the greatest long-term advantages of this procedure.


Subject(s)
Meningomyelocele , Neurosurgery , Spina Bifida Cystica , Spinal Dysraphism , Child , Chile/epidemiology , Female , Gestational Age , Humans , Infant , Infant, Newborn , Meningomyelocele/surgery , Pregnancy , Spina Bifida Cystica/diagnostic imaging , Spina Bifida Cystica/surgery , Spinal Dysraphism/surgery
3.
Int. arch. otorhinolaryngol. (Impr.) ; 23(4): 422-426, Out.-Dez. 2019. ilus, tab
Article in English | LILACS | ID: biblio-1024327

ABSTRACT

Introduction: Chronic rhinosinusitis (CRS) is a highly prevalent pathology in our society. Due to the prevalence of this condition and to the persisting symptoms despite an appropriate medical treatment, surgical techniques are often required. Lately, minimal invasive techniques have been described, such as lacrimal diversion devices (LDDs). This technique offers a fast and convenient choice for delivery of sinus irrigation and topical medication. Objective: We aimed to describe our experience with LDDs and evaluate the safety and effectiveness of the procedure in patients with moderate to severe CRS without nasal polyposis (CRSsNP) and persistent symptomatology despite medical therapy. Methods: A total of 7 patients underwent bilateral lacrimal stents placement in the operating room. A retrospective observational study was conducted. The Sino-Nasal Outcome Test-20 (SNOT-20) survey was performed and the score obtained was compared before and 1 month after the procedure. Results: The LDDs were used for an average of 80 days. During the follow-up, only three patients had a mild complication with the device (granuloma in the punctum, obstruction, and early extrusion). The mean baseline SNOT-20 score dropped significantly ( p = 0.015) from 25.85 to 11.57 (mean: - 14.29) 1 month after the procedure. Conclusion: According to our experience and results, the use of LDD is a novel, feasible, and less invasive technique to treat refractory CRS. It reduces the risk of mucosal stripping, provides short-term outcomes, and the surgical procedure does not require advanced training in endoscopic sinus surgery. Moreover, it can be performed in-office under local anesthesia or sedation (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Sinusitis/surgery , Stents , Rhinitis/surgery , Nasal Surgical Procedures/methods , Retrospective Studies , Minimally Invasive Surgical Procedures/methods , Lacrimal Apparatus/surgery
4.
Int Arch Otorhinolaryngol ; 23(4): e422-e426, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31649762

ABSTRACT

Introduction Chronic rhinosinusitis (CRS) is a highly prevalent pathology in our society. Due to the prevalence of this condition and to the persisting symptoms despite an appropriate medical treatment, surgical techniques are often required. Lately, minimal invasive techniques have been described, such as lacrimal diversion devices (LDDs). This technique offers a fast and convenient choice for delivery of sinus irrigation and topical medication. Objective We aimed to describe our experience with LDDs and evaluate the safety and effectiveness of the procedure in patients with moderate to severe CRS without nasal polyposis (CRSsNP) and persistent symptomatology despite medical therapy. Methods A total of 7 patients underwent bilateral lacrimal stents placement in the operating room. A retrospective observational study was conducted. The Sino-Nasal Outcome Test-20 (SNOT-20) survey was performed and the score obtained was compared before and 1 month after the procedure. Results The LDDs were used for an average of 80 days. During the follow-up, only three patients had a mild complication with the device (granuloma in the punctum, obstruction, and early extrusion). The mean baseline SNOT-20 score dropped significantly ( p = 0.015) from 25.85 to 11.57 (mean: - 14.29) 1 month after the procedure. Conclusion According to our experience and results, the use of LDD is a novel, feasible, and less invasive technique to treat refractory CRS. It reduces the risk of mucosal stripping, provides short-term outcomes, and the surgical procedure does not require advanced training in endoscopic sinus surgery. Moreover, it can be performed in-office under local anesthesia or sedation.

5.
Childs Nerv Syst ; 33(7): 1083-1099, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28593553

ABSTRACT

Accurate and timely prenatal diagnosis of spina bifida (SB) is a major goal of modern antenatal care. Prenatal screening for open SB should be first performed at the time of routine first-trimester ultrasound by examining the posterior fossa for obliteration or non-visualization of the fourth ventricle ("intracranial translucency") and cisterna magna. The second step of screening is the second-trimester anatomy scan, at which time the features of the Chiari type II malformation should be looked for, including ventriculomegaly, scalloping of the frontal bones ("lemon" sign), and backward and caudal displacement of the cerebellar vermis with obliteration of the cisterna magna ("banana" sign). In cases with positive findings, evaluation must include a focused examination of the spine for defects. In cases of closed SB and SB occulta, the cranial and posterior fossa features will not be present as they are not associated with leaking of spinal fluid and resultant hindbrain herniation, highlighting the fact that the spine should be examined thoroughly whenever possible during the second-trimester scan. In tertiary fetal medicine centers, two-dimensional and three-dimensional ultrasound allows an accurate determination of the location, type, extent, and upper level of the spinal defect as well as the presence of associated anomalies. Fetal magnetic resonance imaging should be restricted to candidates for intrauterine surgery as part of the preoperative protocol.


Subject(s)
Prenatal Diagnosis/methods , Spinal Dysraphism/diagnostic imaging , Spinal Dysraphism/surgery , Gestational Age , Humans , Magnetic Resonance Imaging , Ultrasonography , Ultrasonography, Prenatal
6.
Childs Nerv Syst ; 33(7): 1169-1175, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28547209

ABSTRACT

BACKGROUND: Administering anesthesia for prenatal repair of myelomeningocele reveals several issues that are unique to this new form of treatment. This includes issues such as fetal well-being, surgical conditions and monitoring, among others. Exploring, analyzing, and understanding the different variables that are involved will help us reduce the high level of risk associated with this surgery. OBJECTIVE: This review provides a systematic approach to the issues that are faced by anesthesiologists during fetal surgery.


Subject(s)
Anesthesia/methods , Fetal Diseases/surgery , Meningomyelocele/surgery , Neurosurgical Procedures/methods , Fetus , Humans , Prenatal Diagnosis
7.
Lima; s.n; 2016. 84 p. tab, graf.
Thesis in Spanish | LIPECS | ID: biblio-1114253

ABSTRACT

Introducción: La sepsis neonatal temprana es un cuadro clínico caracterizado por manifestaciones de infección sistémica que aparece en las primeras 72 horas de vida, en México se encuentran tasas de entre 0.76 y 4.7 por 1000 nacidos vivos, con una letalidad de entre 5.7 por ciento y 9 por ciento. Objetivos: Determinar las características clínicas de los recién nacidos con sepsis neonatal temprana en el Hospital Nacional Dos de Mayo durante el 2015. Diseño: Estudio descriptivo. Lugar: Hospital Nacional Dos de Mayo. Participantes: Pacientes del servicio de Neonatología diagnosticados con sepsis neonatal temprana posible, probable y confirmada. Intervención: Recolección de datos a través de la base de datos de los pacientes del servicio de Neonatología y revisión de historias clínicas. Resultados: Se incluyeron 479 pacientes, 5.4 por ciento fueron confirmados con hemocultivo. 85.4 por ciento fueron neonatos a término, el 75.8 por ciento tuvo adecuado peso al nacer. El factor de riesgo más frecuente fue la ITU en el tercer trimestre del embarazo. La ictericia fue el signo más común y la PCR > 10 mg/dL el hallazgo de laboratorio más frecuente. El estafilococo coagulasa negativo fue el patógeno aislado en la mayoría de casos. 0.83 por ciento del total pacientes fallecieron. Conclusiones: La frecuencia de sepsis neonatal temprana confirmada en el Hospital Nacional Dos de Mayo en el 2015 fue de 9 por 1000 nacidos vivos, la tasa de letalidad fue de 11.5 por ciento.


Introduction: Early-onset neonatal sepsis is a clinical syndrome characterized by manifestations of systemic infection that appears in the first 72 hours of life, in Mexico there are rates between 0.76 and 4.7 per 1000 newborns, with a lethality rate between 5.7 and 9 per cent. Objective: To determinate the clinical features of newborns with early-onset neonatal sepsis in the National Hospital Dos de Mayo during 2015. Design: Descriptive study. Place: National Hospital Dos de Mayo. Participants: Patients from the Neonatology service diagnosed with possible, likely and confirmed early-onset neonatal sepsis. Intervention: Data collection through the Neonatology service patients' database and clinical record review. Results: 479 patients were included, 5.4 per cent were confirmed by blood culture. 85.4 per cent were term infants, 75.4 per cent had adequate birth weight. The most frequent risk factor was the UTI in the third trimester of pregnancy. Jaundice was the most common sign and CRP > 10 mg/dL the most frequent laboratory finding. Coagulase negative Staphylococcus was the most common insolated pathogen. 0.83 per cent of the patients passed away. Conclusions: The frequency of confirmed early-onset neonatal sepsis in the Dos de Mayo National Hospital during 2015 was 9 per 1000 newborns, the lethality rate was 11.5 per cent.


Subject(s)
Male , Female , Humans , Infant, Newborn , Risk Factors , Perinatal Death , Sepsis , Signs and Symptoms , Retrospective Studies , Cross-Sectional Studies
8.
Prenat Diagn ; 29(8): 794-9, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19449324

ABSTRACT

OBJECTIVE: To report our experience with the management of triplet pregnancies complicated by an acardiac fetus. METHODS: During the 5-year period from 2003 to 2008, five cases were identified. The prenatal sonographic findings, antepartum course, antenatal intervention if performed, and perinatal outcome of each case were reviewed. RESULTS: Four pregnancies were spontaneously conceived and one was achieved by in vitro fertilization. Three pregnancies were dichorionic and two were monochorionic, and two acardiac fetuses were part of a monoamniotic set. All cases underwent an early sonographic examination, but the diagnosis was only made in the first trimester in only two cases, as the acardiac fetus was overlooked or inaccurately identified as a dead fetus in the remaining three cases. Early fetal demise before 12 weeks occurred in a case of monochorionic-triamniotic triplets. Percutaneous laser coagulation of the main intra-abdominal vessel was attempted at 17 weeks in two cases, with subsequent delivery after 34 weeks and perinatal survival of three of the four structurally normal fetuses. In the other two pregnancies which were managed expectantly, both were complicated by severe preterm delivery with perinatal survival of three of the four structurally normal fetuses. Overall, there were no survivors in one case, one twin survived in two cases, and two twins survived in the remaining two cases. None of the survivor had neurological sequelae. CONCLUSIONS: The presence of an acardiac fetus in a triplet pregnancy carries a high risk for poor pregnancy outcome, including fetal death and severe preterm labor. Prenatal intervention may be indicated in some cases, but does not prevent fetal death of the pump twin.


Subject(s)
Abnormalities, Multiple/embryology , Fetal Heart/abnormalities , Heart Defects, Congenital/embryology , Pregnancy Complications , Triplets , Abnormalities, Multiple/diagnostic imaging , Abnormalities, Multiple/pathology , Adult , Female , Fetal Death , Fetofetal Transfusion/pathology , Fetofetal Transfusion/surgery , Heart Defects, Congenital/diagnostic imaging , Heart Defects, Congenital/pathology , Humans , Obstetric Labor, Premature , Pregnancy , Ultrasonography, Prenatal
10.
Prenat Diagn ; 28(6): 531-4, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18509856

ABSTRACT

OBJECTIVES: To review our experience with the prenatal detection of congenital diaphragmatic hernia (CDH) in fetuses presenting for ultrasound screening of chromosomal abnormalities in the first trimester. METHODS: As part of our first-trimester ultrasound protocol, fetuses with a crown-rump length between 45 and 84 mm underwent a limited anatomical assessment in conjunction with nuchal translucency thickness measurement and nasal bone assessment. Cases of CDH diagnosed prenatally or after delivery in this population were identified. RESULTS: Among the six cases of CDH detected (prevalence of 1 in 927), the first-trimester ultrasound findings were abnormal in five fetuses (83%), including three with increased nuchal translucency only; one with increased nuchal translucency, an intrathoracic stomach, dextrocardia and a cephalocele; and one with normal nuchal translucency thickness and a small, complex intrathoracic mass later confirmed as the fetal stomach. The diagnosis of CDH was confidently made in the first trimester in one case, in the second trimester in three cases, and after birth in the remaining two cases. CONCLUSION: The diagnosis of CDH in the first trimester is difficult, especially in those cases in which the defect is small or late migration of the abdominal viscera occurs. Therefore, screening for CDH in the first trimester is unlikely to be effective.


Subject(s)
Aneuploidy , Hernia, Diaphragmatic/diagnostic imaging , Pregnancy Trimester, First , Ultrasonography, Prenatal , Adult , Cephalometry , Crown-Rump Length , Female , Hernias, Diaphragmatic, Congenital , Humans , Male , Mass Screening , Nasal Bone/diagnostic imaging , Nuchal Translucency Measurement , Pregnancy , Pregnancy Outcome , Pregnancy Trimester, Second
11.
Prenat Diagn ; 27(11): 1033-8, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17705212

ABSTRACT

OBJECTIVE: In order to assess the outcome of pregnancies complicated by severe second trimester twin-twin transfusion syndrome (TTTS) undergoing treatment with endoscopic laser surgery, we reviewed our experience following the implementation of an institutional fetal surgery program. METHODS: Patients presenting with monochorionic-diamniotic twin pregnancies complicated by severe TTTS before 26 weeks of gestation were offered endoscopic laser surgery to coagulate placental vascular anastomoses. Using regional anesthesia and guided by real-time sonography, anastomoses were identified and selectively coagulated. At the end of the procedure, amniodrainage was performed to restore normal amniotic fluid volume. Follow-up and delivery were carried out at the referring institutions. Six-month follow-up was performed in all cases. RESULTS: During a 3-year period from September 2003 to December 2006, 33 consecutive cases of severe TTTS were operated on at a median gestational age of 21 weeks (range 17-25). Nine (27.3%) cases were classified as stage II, 21 (63.6%) as stage III, and three (9.1%) as stage IV. The placenta was anterior or predominantly anterior in 15 (45.5%) of the cases. Overall, both twins were born alive in 16 (48.5%) cases, only one twin was born alive in 11 (33.3%), and neither was born alive in the remaining six (18.2%). Therefore, 81.8% (27 of 33) of the pregnancies resulted in at least one liveborn infant. Among them, the mean gestational age at delivery was 32 weeks (range 23-38) and the mean birthweight of the liveborn infants was 1591 g (range 350-3800). Thirty-four infants survived the perinatal period, yielding an overall perinatal survival rate of 51.5%, with 75.8% (25 of 33) of the pregnancies resulting in at least one perinatal survivor. All neonatal deaths were associated with extreme prematurity. CONCLUSIONS: This preliminary experience suggests that selective laser coagulation appears to be a good treatment option in cases of monochorionic twin pregnancies complicated by severe TTTS. However, technical skills and adequate equipment are required for implementing a fetal surgery program. Auditing outcomes during the learning curve would help in identifying potential problems.


Subject(s)
Fetofetal Transfusion/surgery , Fetoscopy/methods , Laser Therapy , Pregnancy Trimester, Second , Twins , Adult , Birth Weight , Endoscopy/methods , Female , Humans , Infant, Newborn , Latin America , Pregnancy , Pregnancy Outcome , Retrospective Studies
12.
J Ultrasound Med ; 26(9): 1215-20, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17715316

ABSTRACT

OBJECTIVE: The purpose of this study was to examine the value of 3-dimensional power Doppler sonography in the prenatal diagnosis of a true knot of the umbilical cord. METHODS: Cases in which the diagnosis of a true knot of the umbilical cord was suspected by prenatal 2-dimensional sonography were reviewed. The presumably affected segment of the cord was examined with 3-dimensional power Doppler sonography for further characterization. Confirmation of the prenatal diagnosis was sought by reviewing the delivery records and contacting the referring obstetrician and the patients themselves. RESULTS: Eight consecutive cases were studied. Three-dimensional power Doppler sonography displayed a vascular spatial configuration pattern consistent with a true knot of the umbilical cord in all of them. However, the prenatal diagnosis was confirmed at delivery in only 5 cases (62.5%). Although there were no cases of a false knot mimicking a true knot of the umbilical cord, all incorrect diagnoses in this series were associated with multiple loops of the umbilical cord in the third trimester. CONCLUSIONS: Three-dimensional power Doppler sonography seems to be helpful in determining the presence of a true knot of the umbilical cord in utero, especially in the second trimester. However, this should not be considered a definitive method for the diagnosis because multiple loops of the umbilical cord lying close to each other can generate a sonographic image that can be undistinguishable from a true knot of the umbilical cord prenatally, especially when located in a small pocket of amniotic fluid. Therefore, the presumable diagnosis of a true knot of the umbilical cord in utero should be taken with caution.


Subject(s)
Imaging, Three-Dimensional , Ultrasonography, Doppler , Ultrasonography, Prenatal , Umbilical Cord/diagnostic imaging , Adult , Female , Humans , Predictive Value of Tests , Pregnancy , Prospective Studies , Umbilical Cord/pathology
13.
J Minim Invasive Gynecol ; 14(1): 108-12, 2007.
Article in English | MEDLINE | ID: mdl-17218240

ABSTRACT

STUDY OBJECTIVE: To verify the efficacy and safety of minilaparotomy hysterectomy using a self-retaining elastic abdominal retractor. DESIGN: Retrospective study (Canadian Task Force classification II-3). SETTING: Private hospital, department of obstetrics and gynecology. PATIENTS: One-hundred-fifty women, age 37 to 76 years, with benign uterine pathology or preinvasive neoplasia. INTERVENTION: Minilaparotomy hysterectomy assisted by a self-retaining elastic abdominal retractor. MEASUREMENTS AND MAIN RESULTS: The mean surgical time was 70 +/- 23.5 minutes (95% CI 63.1-70.7). There were no intraoperative complications. There was no need to extend the initial incision. Eight patients developed complications during the immediate postoperative period (fever in 2, hematoma of the surgical wound in 2, sub-aponeurotic seroma in 2, pubic edema in 1, and pulmonary embolism in 1). During the late postoperative period, a vaginal cuff dehiscence was reported. Mean postoperative hospital stay was 2.5 +/- 0.2 days (95% CI 2.4-2.6). CONCLUSION: Minilaparotomy hysterectomy assisted by a self-retaining abdominal elastic retractor is a safe and effective minimally invasive procedure. Also, it appears to be a good alternative to laparoscopic hysterectomy for institutions that do not have the required expensive equipment or for gynecologists who do not have laparoscopic experience.


Subject(s)
Hysterectomy/instrumentation , Laparotomy/instrumentation , Postoperative Complications/prevention & control , Adult , Female , Hospitals, Private , Humans , Hysterectomy/adverse effects , Hysterectomy/methods , Laparotomy/adverse effects , Laparotomy/methods , Middle Aged , Retrospective Studies
14.
Obstet Gynecol ; 106(4): 797-801, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16199638

ABSTRACT

OBJECTIVE: To report our experience with the management of twin pregnancies discordant for lower urinary tract obstruction. METHODS: Cases of twin pregnancies discordant for lower urinary tract obstruction were identified from our fetal medicine database. Information on ultrasonographic findings, antenatal course, pregnancy complications, and perinatal outcome was obtained by reviewing medical records or contacting the referring obstetricians. RESULTS: Five twin pregnancies discordant for lower urinary tract obstruction were diagnosed between 11 and 15 weeks of gestation. There were 3 dichorionic and 2 monochorionic pregnancies (1 diamniotic and 1 monoamniotic). The dichorionic pregnancies were managed conservatively, resulting in a pregnancy loss of both twins in 1 case, a single fetal death at 29 weeks in 1 case, and an early neonatal death due to lung hypoplasia of the affected twin in 1 case. On the other hand, both monochorionic twin pregnancies were managed with serial vesicocenteses. In both cases, the prenatal course was complicated, 1 by premature rupture of the membranes and the other by cord entanglement, requiring delivery at 29 and 31 weeks, respectively. Among the 4 continuing pregnancies with complete perinatal outcome, none of the affected twins survived, and the structurally normal twins were delivered between 29 and 36 weeks and discharged from the hospital in good condition. CONCLUSION: Twin pregnancies discordant for lower urinary tract obstruction are at high risk of perinatal death and premature delivery. Prenatal intervention seems not to be associated with an improved perinatal outcome of the affected twin, but it may be beneficial in selected cases to attain viability of the unaffected twin.


Subject(s)
Diseases in Twins/diagnosis , Diseases in Twins/therapy , Fetal Diseases/diagnosis , Fetal Diseases/therapy , Urethral Obstruction/diagnosis , Urethral Obstruction/therapy , Diseases in Twins/congenital , Female , Gestational Age , Humans , Pregnancy , Pregnancy Outcome , Retrospective Studies , Treatment Outcome , Ultrasonography, Prenatal , Urethral Obstruction/congenital
16.
Obstet Gynecol ; 102(5 Pt 1): 1028-33, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14672481

ABSTRACT

OBJECTIVE: To review the prenatal complications, management, and perinatal outcome in pregnancies complicated by placental chorioangioma. METHODS: Cases of placental chorioangioma diagnosed prenatally as part of a prospective, multicentric program for fetal diagnosis and therapy were identified. All cases were evaluated with color flow imaging. In the latter part of the study, three-dimensional power Doppler angiography was also used to study the vascular pattern of the tumor. Information on maternal demographics, prenatal sonographic findings, pregnancy complications, antenatal intervention, and perinatal outcome was obtained by reviewing the medical records or contacting the referring obstetricians. RESULTS: In the 5-year period from January 1997 to December 2001, 11 cases of placental chorioangioma were diagnosed prenatally. Nine cases were diagnosed in singleton and two in twin pregnancies. Among the nine cases occurring in singletons, five (56%) were associated with pregnancy complications, including polyhydramnios (n = 3), oligohydramnios (n = 2), fetal growth restriction (n = 2), and nonimmune hydrops (n = 1). Amniodrainage was required in one of these cases, allowing prolongation of pregnancy until term. Four (44%) singletons delivered before 35 weeks. Overall, two fetuses died, including one twin due to complications of twin-twin transfusion syndrome and another with hydrops after alcohol injection into the chorioangioma. In four pregnancies, no prenatal complications were detected in spite of continuous growth and vascularity of the placental mass in three of them. CONCLUSION: Placental chorioangioma is associated with an increased risk of pregnancy complications, the most common being polyhydramnios and preterm delivery. In selected cases, amniodrainage allows continuation of the pregnancy with improving perinatal outcome. Fetuses who develop hydrops are at the highest risk for perinatal death, with limited therapeutic options being available. Close follow-up is advised, even in those cases with no associated findings at the time of the diagnosis.


Subject(s)
Hemangioma/epidemiology , Placenta Diseases/epidemiology , Pregnancy Outcome , Prenatal Diagnosis , Uterine Neoplasms/epidemiology , Adult , Angiography , Chile/epidemiology , Female , Hemangioma/diagnosis , Hemangioma/diagnostic imaging , Hemangioma/etiology , Humans , Medical Records , Placenta Diseases/diagnosis , Placenta Diseases/diagnostic imaging , Placenta Diseases/etiology , Pregnancy , Prospective Studies , Retrospective Studies , Uterine Neoplasms/diagnosis , Uterine Neoplasms/diagnostic imaging , Uterine Neoplasms/etiology
SELECTION OF CITATIONS
SEARCH DETAIL